MEDAX is a wholesaler in Kortrijk. Private Limited, started on 16 April 2007, 1 establishment.

What is the address of MEDAX?

The registered office of MEDAX is located at Diksmuidekaai(Kor) 5 box 21, 8500 Kortrijk.

Is MEDAX still active?

Yes. According to the CBE (19 September 2026) MEDAX is active, legal situation “Normale toestand”, started on 16 April 2007.

Is MEDAX registered on Peppol?

Yes, MEDAX is registered on the Peppol network with ID 0208:0888755867.

What is the enterprise number of MEDAX?

The enterprise number of MEDAX is BE0888755867.

When was MEDAX founded?

MEDAX was founded on 16 April 2007.

Who are the directors of MEDAX?

According to the 2025 annual accounts, the directors of MEDAX are: BERTRAND DELBAR.

Is MEDAX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 April 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDAX make in 2025?

MEDAX recorded a loss after taxes of € 6,168 in financial year 2025.

What is the revenue of MEDAX?

As a small company, MEDAX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 11,821.

MEDAX (Private Limited) - Kortrijk - BE0888755867

Dossier MEDAX, printed on 19 September 2026 from databakkes.be/en/0888755867/medax. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDAX from Kortrijk, company number BE0888755867, closed financial year 2025 with a result of € -6,168 after tax. For that financial year MEDAX recorded a gross margin of € 11,821 and equity of € 75,621. Compared with financial year 2024, the result moved from € 2,906 to € -6,168. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 75,621

▼ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,168

▼ still € 2,906 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 88,974

▲ € 84,356 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 69,421.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 36,549

▼ 30% vs 2024

Of which on lease € 36,549.

Debts at end 2025

Bank debt

€ 9,532

▼ 67% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 49,549

▲ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 826

▼ 66% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 40,265 Gross margin 2022: € 40,265 First fiscal year in the series	€ 18,200 Gross margin 2023: € 18,200 ▼ 55% vs 2022 (€ 40,265) Unfavourable step	€ 24,199 Gross margin 2024: € 24,199 ▲ 33% vs 2023 (€ 18,200) Favourable step	€ 11,821 Gross margin 2025: € 11,821 ▼ 51% vs 2024 (€ 24,199) Unfavourable step	▼ 51%
Profit after taxes	€ 31,377 Profit after taxes 2022: € 31,377 First fiscal year in the series	€ -4,951 Profit after taxes 2023: € -4,951 ▼ € 36,328 vs 2022 (€ 31,377) Unfavourable step	€ 2,906 Profit after taxes 2024: € 2,906 ▲ € 7,857 vs 2023 (€ -4,951) Favourable step	€ -6,168 Profit after taxes 2025: € -6,168 ▼ € 9,074 vs 2024 (€ 2,906) Unfavourable step	▼ € 9,074
Equity	€ 93,834 Equity 2022: € 93,834 First fiscal year in the series	€ 88,883 Equity 2023: € 88,883 ▼ 5% vs 2022 (€ 93,834) Unfavourable step	€ 91,789 Equity 2024: € 91,789 ▲ 3% vs 2023 (€ 88,883) Favourable step	€ 75,621 Equity 2025: € 75,621 ▼ 18% vs 2024 (€ 91,789) Unfavourable step	▼ 18%
Total debts	€ 51,418 Total debts 2022: € 51,418 First fiscal year in the series	€ 97,360 Total debts 2023: € 97,360 ▲ 89% vs 2022 (€ 51,418) Unfavourable step	€ 77,151 Total debts 2024: € 77,151 ▼ 21% vs 2023 (€ 97,360) Favourable step	€ 61,522 Total debts 2025: € 61,522 ▼ 20% vs 2024 (€ 77,151) Favourable step	▼ 20%
Cash	€ 7,033 Cash 2022: € 7,033 First fiscal year in the series	€ 6,268 Cash 2023: € 6,268 ▼ 11% vs 2022 (€ 7,033) Unfavourable step	€ 4,618 Cash 2024: € 4,618 ▼ 26% vs 2023 (€ 6,268) Unfavourable step	€ 88,974 Cash 2025: € 88,974 ▲ € 84,356 vs 2024 (€ 4,618) Favourable step	▲ € 84,356
Retained profit	€ 87,634 Retained profit 2022: € 87,634 First fiscal year in the series	€ 82,683 Retained profit 2023: € 82,683 ▼ 6% vs 2022 (€ 87,634) Unfavourable step	€ 85,589 Retained profit 2024: € 85,589 ▲ 4% vs 2023 (€ 82,683) Favourable step	€ 69,421 Retained profit 2025: € 69,421 ▼ 19% vs 2024 (€ 85,589) Unfavourable step	▼ 19%
Dividend	€ 20,000 Dividend 2022: € 20,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 20,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Dividend 2025: € 10,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 48,145 Bank debt 2023: € 48,145 Unchanged (€ 0) Unfavourable step	€ 28,684 Bank debt 2024: € 28,684 ▼ 40% vs 2023 (€ 48,145) Favourable step	€ 9,532 Bank debt 2025: € 9,532 ▼ 67% vs 2024 (€ 28,684) Favourable step	▼ 67%
Balance sheet total	€ 145,252 Balance sheet total 2022: € 145,252 First fiscal year in the series	€ 186,243 Balance sheet total 2023: € 186,243 ▲ 28% vs 2022 (€ 145,252) Unchanged	€ 168,940 Balance sheet total 2024: € 168,940 ▼ 9% vs 2023 (€ 186,243) Unchanged	€ 137,143 Balance sheet total 2025: € 137,143 ▼ 19% vs 2024 (€ 168,940) Unchanged	▼ 19%

Key figures of MEDAX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDAX?

What happened at MEDAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: loss of € 6,168 (▼ € 9,074 vs 2024). Source: NBB ↗
May 2, 2007 New establishment in Menen. KBO
Apr 16, 2007 Start of the company according to the CBE. KBO
2007 BERTRAND DELBAR became a director. NBB

In short

From € 31,377 profit in 2022 to € 6,168 loss in 2025.

Paid € 2,655 in corporate taxes since 2022.

Best year ever: 2022, with € 31,377 profit.

Paid out € 30,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDAX? We notify you, reason included.

Follow MEDAX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

BERTRAND DELBAR

MEDAX

Behind MEDAX is BERTRAND DELBAR.

See the full network in the app

Directors

According to the 2025 annual accounts

BERTRAND DELBAR

Director

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Diksmuidekaai(Kor) 5 box 21

8500 Kortrijk

2.162.029.040

Schonekeerstraat 185 box A

8930 Menen

Active since 2 May 2007

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.755.867

VAT number

BE 0888.755.867

Registered office

Diksmuidekaai(Kor) 5 bus 21, 8500 Kortrijk

Names & denominations

MEDAX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 April 2007

Peppol

Active · Active since 25 Mar 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Overige zakelijke dienstverlening, neg

Handel in eigen onroerend goed

Handel in onroerend goed

Overige zakelijke dienstverlening, n.e.g.

Detailhandel in medische en orthopedische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDAX

Financials

What happened to MEDAX?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions